Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate vs Teriparatide Crossover in Osteoporosis
NCT06264609Phase 4Enrolling by invitation
- Start
- Feb 2024
- Primary completion
- Dec 2029
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alendronate, teriparatide in osteoporosis. Started Feb 2024; status: enrolling by invitation.
02
Drugs
alendronateteriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT06264609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06264609.